¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"double back cross"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • double orientation
    ÀÌÁßÁö³²·Â
  • double personality
    ÀÌÁßÀΰÝ
  • double salt
    °ã¿°, º¹¿°
  • double sampling
    ÀÌÁßÇ¥º»ÃßÃâ(¹ý)
  • double stain
    ÀÌÁß¿°»ö
  • double staining
    ÀÌÁß¿°»ö(¹ý)
  • double strand
    ÀÌÁß°¡´Ú
  • double stranded helix
    ÀÌÁß°¡´Ú³ª¼±
  • double touch
    µÎ¼ÕÃËÁø, ½Ö¼öÃËÁø
  • double ureter
    Áߺ¹¿ä°ü, ÀÌÁß¿ä°ü
  • double uterus
    µÎÀÚ±Ã(Áõ), Áߺ¹ÀÚ±Ã(Áõ)
  • double vision
    °ãº¸ÀÓ, º¹½Ã
  • double voiding
    À̴ܹ财
  • double-barreled aorta
    ÀÌÁß°ü´ëµ¿¸Æ
  • double-beam spectrophotometer
    ÀÌÁß¼±ºÐ±¤±¤µµ°è
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • double sensation
    ÀÌÁß°¨°¢
  • double staining
    ÀÌÁß¿°»ö
  • double strand
    ½Ö°¡´Ú, ÀÌÁß¼â
  • double suicide
    ÀÌÁßÀÚ»ì
  • double touch
    µÎ¼ÕÃËÁø, ½Ö¼öÃËÁø
  • double ureter
    Áߺ¹¿ä°ü, ÀÌÁß¿ä°ü
  • double uterus
    µÎÀÚ±ÃÁõ
  • double vision
    (¢¡diplopia) °ãº¸ÀÓ, º¹½Ã
  • double voiding
    À̴ܹ财
  • double arc sign
    ÀÌÁßȰ¡ÈÄ
  • double arcuate scotoma
    ÀÌÁßȰ¾ÏÁ¡
  • double blind method
    ÀÌÁ߸Ͱ˹ý
  • double blind test
    ÀÌÁ߸Ͱ˻ç
  • double bubble sign
    ½Ö¹æ¿ï¡ÈÄ
  • double contrast radiography
    ÀÌÁßÁ¶¿µ¹æ»ç¼±ÃÔ¿µ¼ú
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • muscles of back
    µî±ÙÀ°
  • muscles of back ³ª musculi dorsi
    µî±ÙÀ°, ¹èºÎ±Ù(ÛÎÝ»ÐÉ).
  • muscles of back ³ª musculi dorsi
    µî ±ÙÀ°, ¹èºÎ ±Ù(ÛÎÝ»ÐÉ).
  • mutation, back
    ¿ªµ¹¿¬º¯ÀÌ, º¹±Íµ¹¿¬º¯ÀÌ
  • open back privy
    ±ÞÃë½Äº¯¼Ò(˻̬Ëà̰ËÛ).
  • poker back
    °æÁ÷ ¹è(ÌãòÁÛÎ), ô¼ö °æÈ­.
  • poker back
    °æÁ÷¹è(ÌãòÁÛÎ)
  • positive feed back
    ¾ç¼ºµÇ¸ÔÀ̱â.
  • pyelointerstitial back flow
    ½Å¿ì°£Áú¼º¿ª·ù
  • pyelotubular back flow
    ½Å¿ì¼¼¿ä°ü¼º¿ª·ù
  • regiones dorsi =regions of back
    µî, ¹èºÎ(ÛÎÝ»).
  • reverse mutation =back m.
    º¹±Í(µ¹¿¬)º¯ÀÌ(ÜÖÏýÔÍæÔܨì¶).
  • reverse mutation =back m.
    º¹±Í(µ¹¿¬)º¯ÀÌ(ÜÖÏýÔÍæÔܨì¶).
  • reverse mutation =back m.
    º¹±Í(µ¹¿¬)º¯ÀÌ(ÜÖÏýÔÍæÔܨì¶).
  • straight back syndrome
    Á÷ôÃßÁõ(òÁô±õÐñø).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • cross-reacting antigen
    ±³Â÷¹ÝÀÀ Ç׿ø(Îßó©Úãëëù÷ê«)
  • cross-reacting material
    ±³Â÷¹ÝÀÀ ¹°Áú(Îßó©ÚãëëÚªòõ)
  • cross-reaction
    ±³Â÷¹ÝÀÀ(Îßó©Úãëë)
  • cross-reactivation
    ±³Â÷ÀçȰ¼ºÈ­(Îßó©î¢üÀàõûù)
  • cross-resistance
    ±³Â÷ÀúÇ×(Îßó©î½ù÷)
  • cross-sensitization
    ±³Â÷°¨ÀÛ(Îßó©ÊïíÂ)
  • cross-term diffusion coefficient
    ¹æÇØ È®»ê°è¼ö(Ûªúªüªß¤Íªâ¦)
  • cross tolerance
    ±³Â÷³»¼º(Îßó©Ò±àõ)
  • genetic cross
    À¯Àü ±³Â÷(ë¶îîÎßó©)
  • helical cross
    ³ª¼± ½ÊÀÚ(Õ¢àÁä¨í®)
  • phage cross
    ÆäÀÌÁö ±³Â÷(Îßó©)
  • photoactivated cross-linking
    ±¤ºÎȰ ±³Â÷ ¿¬°á(ÎÃÝ¥üÀÎßó©Ö§Ì¿)
  • three-factor cross
    »ïÀÎÀÚ ±³Â÷ (ß²ì×í­Îßó©)
  • three-point cross
    ¼¼Á¡ ±³Â÷(Îßó©)
  • two-factor cross
    ÀÌÀÎÀÚ ±³Â÷(ì£ì×í­Îßó©)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
BEI back-scattered electron imaging; biological exposure indexes; butanol-extractable iodine
bk back
BOAT back pain outcome assessment team
BP Bachelor of Pharmacy; back pressure; barometric pressure; basic protein; bathroom privileges; bed pa...
BPCS back pain classification scale
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
CCF Cross-correlation functions
CCH Cross-correlation histograms
CMM Cross-modality matching
CP Cross-polarization
CRM Cross-reacting material
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • sagittal cross section
    ½Ã»ó´Ü
    ½Ã»ó¸é
  • conjugate double bond
    ÀÌÁß °áÇÕ
  • double
    ÀÌÁßÀÇ, Áߺ¹ÀÇ
  • double aortic arch
    ÀÌÁß ´ëµ¿¸Æ±Ã
  • double arcuate scotoma
    ÀÌÁß È° ¸ð¾ç ¾ÏÁ¡, ÀÌÁß ±Ã»ó ¾ÏÁ¡
  • double athetosis
    ¾çÃø ¾ÆÅ×Åä
  • double balloon
    ÀÌÁß Ç³¼±
  • double bind
    ÀÌÁß °á¹Ú
  • double blind mothod
    ÀÌÁß ¸Í°Ë¹ý
    ƯÁ¤ ¾à¹°ÀÇ È¿°ú ½ÃÇèÀ» Çϴµ¥ »ç¿ëµÇ´Â ¹æ¹ýÀ¸·Î½á,Åõ¿© ½Ã¿¡ Åõ¿©ÀÚ³ª ¼ö±ÝÀÚ°¡ ±× ¹°ÁúÀÌ È°¼ºÀÎÁö ºÒȰ¼ºÀÎÁö¸¦ ¸ð¸£°Ô ÇÏ´Â °Í.
  • double bubble sign
    ½Ö±âÆ÷ ¡ÈÄ
  • double chambered right ventricle
    ¿ì½É½Ç ¾çºÐÁõ
  • double continued fever
    Áߺ¹ °è·ù ¿­
  • double contrast
    ÀÌÁß Á¶¿µ¼ú
  • double contrast arthrography
    ÀÌÁß °üÀý Á¶¿µ¼ú, ÀÌÁß Á¶¿µ °üÀý Á¶¿µ¼ú
  • double crush syndrome
    ÀÌÁß ºÐ¼â ÁõÈıº
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
cross-cut bur A bur with blades located at right angles to its long axis.
(05 Mar 2000)
cross-dressing Clothing oneself in the clothes of the opposite sex.
See: transvestism.
(05 Mar 2000)
cross-eye Alternative spelling for crossed eyes.
(05 Mar 2000)
cross flap A skin flap transferred from one part of the body to a corresponding part, as from one arm to the other.
(05 Mar 2000)
cross-hybridisation <molecular biology> The hydrogen bonding of asingle-stranded DNA sequence that is partially but not entirely complementary to a single-stranded substrate. Often, this involves hybridising a DNA probe for a specific DNA sequence to the homologous sequences of different species.
(09 Oct 1997)
cross hybridization Annealing of a DNA probe to an imperfectly matching DNA molecule.
(05 Mar 2000)
cross infection <microbiology> Infection transmitted between individuals infected with different pathogenic microorganisms. Any infection which a patient contracts in a health-care institution.
(12 Dec 1998)
cross-link A covalent linkage between two polymers or between two different regions of the same polymer.
(05 Mar 2000)
cross linking 1. <chemistry> The linking of the chains of a polymer to one another so that the polymer, as a network, becomes stronger and more resistant to being dissolved.
2. <molecular biology> The abnormal linking of two strands of DNA by covalent bonds (as opposed to the normal hydrogen bonds between base pairs), which can occur by exposure to X-rays. Such linking is a type of damage to the DNA molecule and must be repaired before the DNA can replicate and function properly again.
(09 Oct 1997)
cross-linking reagent <chemistry> Reagents with two reactive groups, usually at opposite ends of the molecule, that are capable of reacting with and thereby forming bridges between side chains of amino acids in proteins; the locations of naturally reactive areas within proteins can thereby be identified; may also be used for other macromolecules, like glycoproteins, nucleic acids, or other.
(12 Dec 1998)
cross-matching 1. A test for incompatibility between donor and recipient blood, carried out prior to transfusion to avoid potentially lethal haemolytic reactions between the donor's red blood cells and antibodies in the recipient's plasma, or the reverse; performed by mixing a sample of red blood cells of the donor with plasma of the recipient (major crossmatch) and the red blood cells of the recipient with the plasma of the donor (minor crossmatch). Incompatibility is indicated by clumping of red blood cells and contraindicates use of the donor's blood.
2. In allotransplantation of solid organs (e.g., kidney), a test for identification of antibody in the serum of potential allograft recipients which reacts directly with the lymphocytes or other cells of a potential allograft donor; presence of these antibodies usually, if not always, contraindicates the performance of the transplantation because virtually all such grafts will be subject to a hyperacute type of rejection.
(05 Mar 2000)
cross-pollination <botany> Fertilization of a plant from a plant with a different genetic makeup.
(09 Oct 1997)
cross-reacting agglutinin An immune agglutinin specific for a group antigen.
Synonym: cross-reacting agglutinin.
(05 Mar 2000)
cross-reacting antibody <immunology> Antibody specific for group antigens, i.e., those with identical functional groups, antibody for antigens that have functional groups of closely similar, but not identical, chemical structure.
(05 Mar 2000)
cross-reacting material <haematology> A substance sufficiently different from a reference substance (R) to have a perceptibly different function from R but sufficiently similar to R that it reacts with anti-R antibodies; e.g., mutant factor VIII may be defective or even inert in coagulation and yet be immunologically identified as factor VIII.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • double
    2¹èÀÇ;2ÁßÀÇ;½ÖÀÇ;Ç¥¸®°¡ ÀÖ´Â;°ÅÁþÀÇ;¸ðÈ£ÇÑ;2¹èÇÏ´Ù;°ãÄ¡´Ù;Á¢´Ù;2¹è°¡µÇ´Ù;´Þ¸®´Ù;ÀÏÀ»°âÇÏ´Ù
  • double Dutch
    Åë ¾Ë¾Æ µéÀ» ¼ö ¾ø´Â ¸»
  • double agent
    ÀÌÁß °£Ã¸
  • double ax
    ¾ç³¯ µµ³¢
  • double bar
    (¾Çº¸ÀÇ)°ã¼¼·ÎÁÙ
  • double bass
    =CONTRABASS
  • double bassoon
    ´õºí¹Ù¼ø;ÄÜÆ®¶ó ¹Ù¼ø
  • double bed
    ´õºíº£µå;2Àοë ħ´ë
  • double bill
    ¿µÈ­;¿¬±ØÀÇ 2Æí µ¿½Ã »ó¿µ
  • double bind
    (Á¤ÀÇ)2Áß ±¸¼Ó(¾î¸°ÀÌ µîÀÌ 2°³ÀÇ ¸ð¼øµÈ ¸í·É,¿ä±¸¸¦ ¹ÞÀº °æ¿ì);µô·¹¸¶
  • double blind
    (ÀÇ)(¾àÀÇ È¿°ú¸¦ ÆÇÁ¤ÇÏ´Â ¹æ¹ý¿¡¼­)2Áß ¸Í°ËÀÇ
  • double bogey
    (°ñÇÁ)´õºíº¸±â(ÆÄ º¸´Ù 2Ÿ ´õ Ãļ­ Ȧ¿¡ ³Ö±â)
  • double boiler
    ÀÌ2Áß ³¿ºñ !
  • double bond
    (È­)ÀÌÁß °áÇÕ
  • double bottom
    (»óÀÚ,¹è µîÀÇ)°ã¹Ù´Ú
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
ÅëÇÕ°Ë»ö ¿Ï·á